
Guerbet is a limited liability company incorporated under the laws of France with securities listed on Euronext Paris, France. Consequently, our corporate governance framework reflects the mandatory provisions of French corporate law, the securities laws and regulations applying to Guerbet as a corporation listed in France States. In addition, the Company’s corporate governance principles refer to the AFEP-MEDEF Code.
On May 21, 2010, Guerbet adopted the French form of a joint stock company governed by a Board of Directors (Société Anonyme à Conseil d'administration). This legal structure upholds a clear separation between management functions assumed by the Executive Committee and the functions of oversight assured by the Board of Directors, which represents the shareholders.
Board of Directors

Hugues Lecat
Chairman of the Board of Directors

Carine Dagommer
Director

Eric Drapé
Independent Director

Marie de La Simone
Employee Director

Eric Guerbet
Director

Céline Lamort
Director

Michèle Lesieur
Independent Director

Nicolas Louvet
Director

Marc Massiot
Director
Executive Committee

David Hale
Chief Executive Officer

Christine Allard
SVP Public Affairs and Corporate Communications

Charlotte Bamière
General Counsel & SVP Compliance

Raoul Bernhardt
SVP Industrial Operations, EHS and Procurement

Philippe Bourrinet
SVP Development, Medical & Regulatory Affairs and Group Responsible Pharmacist

Valérie Brissart
SVP Marketing - Diagnostic Imaging

Jérôme Estampes
Chief Financial Officer and SVP Business Development & Licensing

François Nicolas
SVP Research, Development, Innovation and AI

Eva Ohlsson
SVP Human Resources

Dan Raffi
SVP Commercial Operations